Skip to content

MEDIKEMOS

Active Private limited companyfounded 2002active for 24 yearsBrugmannlaan 263, 1180 UccleKBO/BCE: BE 0476.914.059

Lifetime

20 annual accounts with figures on one time axis, 24 filings since 2002
peak of €809,149 in 2020
€573,112▼ 18.4%
lowest -€261,931 in 2016
€75,511▼ 31.9%
peak of €507,241 in 2025
€507,241▲ 17.5%
€842,885▼ 18.8%
peak of 6.5 FTE in 2016
-not published
Board1 name since 2002
1 director
Documentsfilings and deeds
25-09-202656 days late
2025micro format
Gross margin from €701,932 to €573,112Result from €110,858 to €75,511Equity from €431,730 to €507,241Debts from €1.0m to €842,885

Key points

from the 2025 annual accounts

Turnover

≈ €880,000 estimated

The accounts state no turnover.

Investments

€31,471 0.3 times depreciation
2021202220232025

Green is investment, beige is depreciation. Machinery stands 913.1% higher than in 2024.

Staff

5 employees on 31-12-2025
542021542022622023142024552025

In 2025, 5 employees joined and 5 left.

Filings

24 annual accounts since 2002
AprilJune31 JulyOctober20102020

Ten of the last ten came late. The 2016 accounts came in latest, 108 days after the end of the period.

Position in the sector

€507,241

More equity than 82% of companies in human health. Sector median €125,064 · 21,339 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as MEDIKEMOS has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,912 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for MEDIKEMOS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 22-12-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0476914059
reappointed as director “exercice de la médecine aiguë et exercice de la médecine de traitement de la calvitie et restauration…” (deed in French) · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 22-12-2023 · Gazette deed
Incorporation published on 01-03-2002 · Gazette deed
First establishment Brugmannlaan 263, Uccle
All 36 events

Comparable companies

same main activity, similar in size and age
Company
MEDIKEMOS Uccle €1.4m €573,112 37.6% -
HZ MEDICAL Brussels €1.3m €638,467 80.9% -
DOKTER FRANK MERTENS Sint-Pieters-Leeuw €1.5m €613,991 90.2% -
LIBAGYN Watermael-Boitsfort €1.1m €494,842 72.6% -
Maison Médicale Neptune Schaerbeek €1.6m €682,074 92.3% 8.3
HORIZON Eeklo €1.5m €510,370 84.5% -
DR. YAMAC AYSE Wijnegem €1.5m €614,714 81.7% -

These companies have the same main activity as MEDIKEMOS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €1.1m and €1.6m, founded between 2002 and 2006.

Official details

Source: KBO
Status
Active since 15-02-2002Normal situation
Registered office
21 active companies are registered at this addressSource: KBO register, as of 17 November 2026.
Activity
General medical practiceNACE 86210and 1 other
Joint committee
330.04Health institutions and services · annual accounts 2024
Establishment unit
2.203.957.8831180 Uccle, since 13-02-2002
Financial year end
31 December
Peppol
Reachable since 12-08-2026
Company details

Annual accounts 2025

€1.4m▼ 8.1%
Employeeson 31-12-2025
5=
Filing
Filed on 25-09-2026
Financials

Insights on MEDIKEMOS

MEDIKEMOS files the micro format. That format states no turnover. The gross margin rose from €23,468 in 2006 to €573,112 in 2025.

The balance sheet grew most from 2011 to 2013 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MEDIKEMOS

What is the company number of MEDIKEMOS?
The company number of MEDIKEMOS is 0476.914.059. The VAT number is the same number with BE in front: BE 0476.914.059.
Where is MEDIKEMOS based?
The registered office is at Brugmannlaan 263, 1180 Uccle.Company details
What does MEDIKEMOS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of MEDIKEMOS?
MEDIKEMOS is a private limited company (BV).
When was MEDIKEMOS founded?
MEDIKEMOS was founded on 15-02-2002.
Is MEDIKEMOS still active?
Yes, MEDIKEMOS is an active enterprise in the KBO register.
How many employees does MEDIKEMOS have?
MEDIKEMOS had an average of 4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does MEDIKEMOS fall under?
In its 2024 annual accounts, MEDIKEMOS states joint committee 330.04 (Health institutions and services).
What is the turnover of MEDIKEMOS?
The turnover in financial year 2025 is ≈ €880,000. This figure is estimated from the gross margin of €573,112 and 38 comparable companies (NACE 862). It probably lies between €760,000 and €1.1m.
Is MEDIKEMOS profitable?
In financial year 2025, MEDIKEMOS made a profit of €75,511.
Where can I find the annual accounts of MEDIKEMOS?
MEDIKEMOS filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEDIKEMOS due?
MEDIKEMOS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.